Ortiz P A, Garvin J L
Hypertension and Vascular Research Division, Henry Ford Hospital, Detroit, Michigan 48202, USA.
Kidney Int. 2000 Nov;58(5):2069-74. doi: 10.1111/j.1523-1755.2000.00379.x.
In vivo and in vitro studies have shown that nitric oxide (NO) is an important modulator of transport processes along the nephron. The thick ascending limb (TAL) plays a significant role in the urine-concentrating mechanism and in the maintenance of acid/base balance.
TALs from male Sprague-Dawley rats were isolated and perfused, and net bicarbonate flux (J(HCO3)(-) was determined.
In perfused TALs, 0.5 mmol/L L-arginine (L-Arg), the substrate for NO synthase, significantly lowered J(HCO3)(-) from 35.4 +/- 4.6 to 23.2 +/- 2.9 pmol. mm(-1). min(-1), a decrease of 36.9 +/- 11.6% (P < 0.025). D-Arg (0.5 mmol/L) had no effect on J(HCO3)(-) (N = 7). In the presence of 5 mmol/L L-NAME, an NO synthase (NOS) inhibitor, the addition of L-Arg did not affect TAL J(HCO3)(-) (43.4 +/- 4.4 vs. 44.6 +/- 5.0 pmol. mm(-1). min(-1)). L-NAME alone (5 mmol/L) did not affect TAL J(HCO3)(-). After removing L-Arg from the bath, J(HCO3)(-) increased from 26.2 +/- 3.9 to 34.8 +/- 3.2 pmol. mm(-1). min(-1) (P < 0.01), indicating no cytotoxicity of NO. We next investigated the effect of cGMP analogues on TAL J(HCO3)(-). 8-Br-cGMP (50 micromol/L) and db-cGMP (50 micromol/L) significantly decreased J(HCO3)(-) by 26.3 +/- 9.1% and 35.1 +/- 11.6%, respectively. In the presence of cGMP (50 micromol/L), the addition of L-Arg had no effect on J(HCO3)(-). In the presence of KT-5823 (2 mircromol/L), a protein kinase G inhibitor, the addition of L-Arg did not change TAL J(HCO3)(-) (N = 5).
We conclude that (1) endogenously produced NO inhibits TAL J(HCO3)(-) in an autocrine manner, (2) cGMP mediates all the effects of NO, and (3) this effect is mediated by protein kinase G activation.
体内和体外研究表明,一氧化氮(NO)是沿肾单位转运过程的重要调节因子。髓袢升支粗段(TAL)在尿液浓缩机制和酸碱平衡维持中起重要作用。
分离雄性Sprague-Dawley大鼠的TAL并进行灌注,测定净碳酸氢盐通量(J(HCO3)(-))。
在灌注的TAL中,NO合酶的底物0.5 mmol/L L-精氨酸(L-Arg)显著降低J(HCO3)(-),从35.4±4.6降至23.2±2.9 pmol·mm(-1)·min(-1),降低了36.9±11.6%(P<0.025)。D-Arg(0.5 mmol/L)对J(HCO3)(-)无影响(N=7)。在存在5 mmol/L L-NAME(一种NO合酶(NOS)抑制剂)的情况下,添加L-Arg不影响TAL的J(HCO3)(-)(43.4±4.4对44.6±5.0 pmol·mm(-1)·min(-1))。单独的L-NAME(5 mmol/L)不影响TAL的J(HCO3)(-)。从浴液中去除L-Arg后,J(HCO3)(-)从26.2±3.9增加到34.8±3.2 pmol·mm(-1)·min(-1)(P<0.01),表明NO无细胞毒性。接下来我们研究了cGMP类似物对TAL的J(HCO3)(-)的影响。8-溴-cGMP(50 μmol/L)和二丁酰-cGMP(50 μmol/L)分别显著降低J(HCO3)(-) 26.3±9.1%和35.1±11.6%。在存在cGMP(50 μmol/L)的情况下,添加L-Arg对J(HCO3)(-)无影响。在存在蛋白激酶G抑制剂KT-5823(2 μmol/L)的情况下,添加L-Arg不改变TAL的J(HCO3)(-)(N=5)。
我们得出结论:(1)内源性产生的NO以自分泌方式抑制TAL的J(HCO3)(-);(2)cGMP介导NO的所有作用;(3)这种作用由蛋白激酶G激活介导。